Publicacións en colaboración con investigadores/as de Hospital Universitario Marqués de Valdecilla (23)

2024

  1. Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial

    The Lancet Infectious Diseases, Vol. 24, Núm. 4, pp. 375-385

  2. Epidemiological and clinical characterization of community, healthcare-associated and nosocomial colonization and infection due to carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Spain

    Infection

2023

  1. A call for the comprehensive diagnosis of viral hepatitis as a key step towards its elimination

    Liver International

  2. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

    Journal of Clinical Virology, Vol. 167

  3. Oportunistic diagnosis based on age and hepatitis C virus clearance: an essential step to improve the overall health of the liver

    Revista Espanola de Enfermedades Digestivas, Vol. 115, Núm. 3, pp. 128-132

  4. Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 2, pp. 150-162

2022

  1. Direct Urine Resistance Detection Using VITEK 2

    Antibiotics, Vol. 11, Núm. 5

  2. Ten steps to eliminating hepatitis C in hospitals

    Nature Reviews Gastroenterology and Hepatology

2021

  1. Application and perspectives of maldi–tof mass spectrometry in clinical microbiology laboratories

    Microorganisms, Vol. 9, Núm. 7

  2. Hepatitis C reflex testing in Spain in 2019: A story of success

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 3, pp. 119-126

  3. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020

    Nature, Vol. 595, Núm. 7869, pp. 707-712

  4. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

2020

  1. In reply to: Confirmation of antibodies against hepatitis C virus by recombinant immunoblot: Is it really an improvement to abandon it?

    Enfermedades Infecciosas y Microbiologia Clinica

2019

  1. Diagnosis of hepatitis C virus infection in Spain: An opportunity to improve

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 4, pp. 231-238

2018

  1. A multicentre study investigating parameters which influence direct bacterial identification from urine

    PLoS ONE, Vol. 13, Núm. 12

2017

  1. HIV type 2 epidemic in Spain: Challenges and missing opportunities

    AIDS, Vol. 31, Núm. 10, pp. 1353-1364

2010

  1. Antimicrobial resistance among respiratory pathogens in Spain: Latest data and changes over 11 years (1996-1997 to 2006-2007)

    Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 7, pp. 2953-2959

  2. Clinical features of infections and colonization by Acinetobacter genospecies 3

    Journal of Clinical Microbiology, Vol. 48, Núm. 12, pp. 4623-4626

2009

  1. Escherichia coli y Klebsiella pneumoniae productoras de betalactamasas de espectro extendido en hospitales españoles: Segundo estudio multicéntrico (proyecto GEIH-BLEE 2006)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 27, Núm. 9, pp. 503-510

2007

  1. Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance

    Journal of Antimicrobial Chemotherapy, Vol. 59, Núm. 4, pp. 698-704